It is with great pleasure that we want to announce the Fourth Congress of the Swiss Federation of Clinical Neuro-Societies (SFCNS), which will take place In Lausanne at the SwissTech Convention Center From October 23 to 25, 2019.
The SFCNS has ever since its foundation undertaken to improve the quality and visibility of Swiss neuroscience locally, nationally and internationally. This has been done with great success by promoting clinical excellence, scientific research as well as political lobbying. This has been done by promoting collaboration and exchange between the various clinical neurosocieties which form it.
Starting with the the 6 original (founding) societies (Neurology, Neurosurgery, Neuroradiology, Neuropediatrics, Neuropathology and Clinical Neurophysiology), the federation has grown to encompass most if not all societies and individuals involved in managing diseases of the central nervous system in Switzerland.
The SFCNS has thus successfully been active in the creation, and certification of world-class stroke centers as well as in defining the criteria by which Highly Specialized Medicine (HSM) is to be practiced in Switzerland in the domain of clinical neurosciences. Since its founding in 2009 and the first congress in 2010, the Federation has continuously grown and expanded its success, vision and influence. In addition to the Congress, the Society has developed with Success Summer Schools to attract its members as well as established the Journal Clinical and Translational Neuroscience as its own vehicle for scientific publications.
Central to the success of the SFCNS lies the Congress, which represents a unique encounter between not just the various societies which form its core but also of adjacent specialities that will contribute to our common future. Thus, it is exceedingly important that the Congress not only represents the various member societies, but also has a spirit of its own.
This Fourth Congress of the SFCNS is this time not just held as previously in a Congress Center but in the heart of Swiss technological innovation at the SwissTech Convention Center, which is located in the heart of the campus of the Ecole Polytechnique Fedeale de Lausanne (EPFL). This represents a breakout from the previous locations in Basel and Montreux. This is of extreme importance to us all since clinical neuroscience has benefited from advances in technology since its inception and leaders in neuroscience very often contribute to technological developments themselves. Therefore, joining the traditional neuroscience participants we will see participants from fields of technologies such as basic neuroimaging, robotics, artificial intelligence that have and will contribute over the next century to define the way we clinical neuroscientists work.
The congress program is extremely rich and varied and proposes a multitude of formats for presenting knowledge and advances in neuroscientific areas: The days will start with plenary Sessions that will be followed by satellite symposia and then parallel sessions devoted to topics of clinical and scientific interest.
We hope that you will join us in Lausanne for this exciting event and that you will have as much pleasure attending the Congress as we had organizing it.
Prof. Karl Olof Lövblad, MD
Prof. Karl Schaller, MD